CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: benzalkonium chloride
Accession: CHEBI:3020
browse the term
Definition: A class of quaternary ammonium chloride salts in which the nitrogen is substituted by a benzyl group, two methyl groups and an even-numbered alkyl chain.
Synonyms: related_synonym: ADBAC; Alkyl dimethylbenzyl ammonium chloride; Alkylbenzyldimethylammonium chloride; Alkyldimethyl(phenylmethyl)quaternary ammonium chlorides; Alkyldimethylbenzylammonium chloride; Formula=C9H13ClNR; SMILES=[Cl-].C[N+](C)([*])Cc1ccccc1; benzalkonii chloridum; benzalkonium chlorides; chlorure de benzalkonium; cloruro de benzalconio
alt_id: MESH:D001548
xref: CAS:8001-54-5; KEGG:C08037; KEGG:D00857
xref_mesh: MESH:D001548
xref: PMID:17660979; PMID:22692451; PMID:23078159; PMID:23102555; PMID:23278376; PMID:23439005; PMID:23519403; PMID:23542350; PMID:23651563; PMID:23682619; PMID:23726247; PMID:23792171; PMID:23861389; PMID:23892748; PMID:23893017; PMID:23987445; PMID:23987991; PMID:23991114; PMID:7526642
G
Aacs
acetoacetyl-CoA synthetase
increases expression
ISO
Benzalkonium Compounds results in increased expression of AACS mRNA
CTD
PMID:31199489
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
G
Abca1
ATP binding cassette subfamily A member 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ABCA1 mRNA
CTD
PMID:26919959
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abca12
ATP binding cassette subfamily A member 12
increases expression
ISO
Benzalkonium Compounds results in increased expression of ABCA12 mRNA
CTD
PMID:25377654
NCBI chr 9:72,822,661...72,995,748
Ensembl chr 9:72,823,350...72,996,049
G
Abca6
ATP binding cassette subfamily A member 6
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ABCA6 mRNA
CTD
PMID:20713136
NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530
G
Acod1
aconitate decarboxylase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ACOD1 mRNA
CTD
PMID:30171875
NCBI chr15:79,871,819...79,881,101
Ensembl chr15:79,871,827...79,880,529
G
Acp6
acid phosphatase 6, lysophosphatidic
increases expression
ISO
Benzalkonium Compounds results in increased expression of ACP6 mRNA
CTD
PMID:31199489
NCBI chr 2:184,711,975...184,733,067
Ensembl chr 2:184,711,619...184,733,017
G
Acsl4
acyl-CoA synthetase long-chain family member 4
increases expression
ISO
Benzalkonium Compounds results in increased expression of ACSL4 mRNA
CTD
PMID:31199489
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Ada
adenosine deaminase
increases expression
ISO
Benzalkonium Compounds results in increased expression of ADA mRNA
CTD
PMID:30171875
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ADH1 mRNA
CTD
PMID:31199489
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
G
Adora1
adenosine A1 receptor
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ADORA1 mRNA
CTD
PMID:30171875
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adra2a
adrenoceptor alpha 2A
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ADRA2A mRNA
CTD
PMID:30171875
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Agtr2
angiotensin II receptor, type 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of AGTR2 mRNA
CTD
PMID:30171875
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Benzalkonium Compounds results in increased expression of AKR1B10 mRNA
CTD
PMID:30806763
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Alb
albumin
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ALB mRNA
CTD
PMID:31199489
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Amigo2
adhesion molecule with Ig like domain 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of AMIGO2 mRNA
CTD
PMID:37149095
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
G
Apoa1
apolipoprotein A1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of APOA1 mRNA
CTD
PMID:31199489
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apoa2
apolipoprotein A2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of APOA2 mRNA
CTD
PMID:31199489
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
G
Apoc1
apolipoprotein C1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of APOC1 mRNA
CTD
PMID:31199489
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression
ISO
Benzalkonium Compounds results in increased expression of AQP3 mRNA
CTD
PMID:30171875
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Areg
amphiregulin
increases expression
ISO
Benzalkonium Compounds results in increased expression of AREG mRNA
CTD
PMID:30171875
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arg2
arginase 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of ARG2 mRNA
CTD
PMID:30171875
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Art3
ADP-ribosyltransferase 3
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ART3 mRNA
CTD
PMID:31199489
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
G
Atf4
activating transcription factor 4
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ATF4 mRNA
CTD
PMID:28236482
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atp5f1e
ATP synthase F1 subunit epsilon
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ATP5F1E mRNA
CTD
PMID:31199489
NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450
G
Atp5mg
ATP synthase membrane subunit G
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ATP5MG mRNA
CTD
PMID:31199489
NCBI chr 8:45,225,680...45,233,630
Ensembl chr 8:45,225,686...45,233,559
G
B3galt4
Beta-1,3-galactosyltransferase 4
affects response to substance
ISO
B3GALT4 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,936,089...4,937,664
Ensembl chr20:4,931,768...4,938,315
G
Bambi
BMP and activin membrane-bound inhibitor
increases expression
ISO
Benzalkonium Compounds results in increased expression of BAMBI mRNA
CTD
PMID:20146380
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Bcl3
BCL3, transcription coactivator
increases expression
ISO
Benzalkonium Compounds results in increased expression of BCL3 mRNA
CTD
PMID:30171875
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
G
Btc
betacellulin
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of BTC mRNA
CTD
PMID:30171875
NCBI chr14:16,708,447...16,746,961
Ensembl chr14:16,707,982...16,747,049
G
C3
complement C3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of C3 mRNA
CTD
PMID:30171875
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp3
caspase 3
increases cleavage multiple interactions
ISO
Benzalkonium Compounds analog results in increased cleavage of CASP3 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Benzalkonium Compounds analog results in increased cleavage of CASP3 protein]
CTD
PMID:31982400
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CASP8 mRNA
CTD
PMID:28236482
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccl11
C-C motif chemokine ligand 11
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCL11 protein
CTD
PMID:30517752
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
increases expression increases secretion
ISO
Benzalkonium Compounds results in increased expression of CCL2 mRNA; Benzalkonium Compounds results in increased expression of CCL2 protein Benzalkonium Compounds results in increased secretion of CCL2 protein
CTD
PMID:30171875 PMID:30517752 PMID:31707104
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCL20 mRNA
CTD
PMID:30806763
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl24
C-C motif chemokine ligand 24
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CCL24 mRNA
CTD
PMID:30171875
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccl3
C-C motif chemokine ligand 3
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of CCL3 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CCL3 protein
CTD
PMID:30517752 PMID:31158415
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
decreases expression increases expression multiple interactions
ISO
Benzalkonium Compounds results in decreased expression of CCL4 mRNA; Benzalkonium Compounds results in decreased expression of CCL4 protein Benzalkonium Compounds results in increased expression of CCL4 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CCL4 protein
CTD
PMID:18353026 PMID:20713136 PMID:30517752 PMID:31158415
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCL5 protein
CTD
PMID:30517752
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCL7 mRNA; Benzalkonium Compounds results in increased expression of CCL7 protein
CTD
PMID:30171875 PMID:30517752
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CCN2 mRNA
CTD
PMID:25377654
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccn3
cellular communication network factor 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCN3 mRNA
CTD
PMID:30171875
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
G
Ccr4
C-C motif chemokine receptor 4
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CCR4 mRNA
CTD
PMID:30171875
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
G
Ccr5
C-C motif chemokine receptor 5
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCR5 mRNA
CTD
PMID:30171875
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd177
CD177 molecule
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CD177 mRNA
CTD
PMID:30171875
NCBI chr 1:80,340,034...80,360,599
Ensembl chr 1:80,340,034...80,360,621
G
Cd274
CD274 molecule
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CD274 mRNA
CTD
PMID:30171875
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd300c2
CD300C molecule 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of CD300C2 mRNA
CTD
PMID:30171875
NCBI chr10:100,253,312...100,258,553
Ensembl chr10:100,253,624...100,258,323
G
Cdc6
cell division cycle 6
multiple interactions decreases expression
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Benzalkonium Compounds results in decreased expression of CDC6 protein] Benzalkonium Compounds results in decreased expression of CDC6 mRNA; Benzalkonium Compounds results in decreased expression of CDC6 protein
CTD
PMID:36725023
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cfap61
cilia and flagella associated protein 61
increases expression
ISO
Benzalkonium Compounds results in increased expression of CFAP61 mRNA
CTD
PMID:31199489
NCBI chr 3:133,354,400...133,633,310
Ensembl chr 3:133,354,197...133,633,320
G
Cfd
complement factor D
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CFD mRNA
CTD
PMID:30171875
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
G
Chi3l1
chitinase 3 like 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of CHI3L1 mRNA
CTD
PMID:30171875
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CHRNB4 mRNA
CTD
PMID:30171875
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
G
Cimap1d
CIMAP1 family member D
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CIMAP1D mRNA
CTD
PMID:30171875
NCBI chr 7:10,049,472...10,065,626
Ensembl chr 7:10,059,589...10,065,125
G
Clcf1
cardiotrophin-like cytokine factor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of CLCF1 mRNA
CTD
PMID:30171875
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
G
Cnfn
cornifelin
increases expression
ISO
Benzalkonium Compounds results in increased expression of CNFN mRNA; Benzalkonium Compounds results in increased expression of CNFN protein
CTD
PMID:25377654
NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747
G
Csf1
colony stimulating factor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of CSF1 protein
CTD
PMID:30517752
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf2
colony stimulating factor 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of CSF2 protein
CTD
PMID:30517752
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf3
colony stimulating factor 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of CSF3 protein
CTD
PMID:30517752
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Ctps1
CTP synthase 1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CTPS1 mRNA
CTD
PMID:30171875
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of CXCL10 mRNA; Benzalkonium Compounds results in increased expression of CXCL10 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL10 protein
CTD
PMID:23445166 PMID:30517752 PMID:31158415
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of CXCL2 mRNA; Benzalkonium Compounds results in increased expression of CXCL2 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL2 protein
CTD
PMID:30171875 PMID:30517752 PMID:31158415
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions increases expression
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CXCL3 mRNA Benzalkonium Compounds results in increased expression of CXCL1 protein; Benzalkonium Compounds results in increased expression of CXCL3 mRNA
CTD
PMID:30171875 PMID:30517752
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
multiple interactions increases expression
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CXCL5 mRNA Benzalkonium Compounds results in increased expression of CXCL5 mRNA; Benzalkonium Compounds results in increased expression of CXCL5 protein
CTD
PMID:30171875 PMID:30517752
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcr1
C-X-C motif chemokine receptor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of CXCR1 mRNA
CTD
PMID:30806763
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
Benzalkonium Compounds results in increased expression of CXCR4 mRNA
CTD
PMID:20713136
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression increases expression
ISO
Benzalkonium Compounds results in decreased expression of CYP1A1 mRNA Benzalkonium Compounds results in increased expression of CYP1A1 mRNA
CTD
PMID:20713136 PMID:30806763
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CYP27A1 mRNA
CTD
PMID:20713136
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp51
cytochrome P450, family 51
increases expression
ISO
Benzalkonium Compounds results in increased expression of CYP51 mRNA
CTD
PMID:31199489
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of DDIT3 mRNA
CTD
PMID:37149095
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dhcr24
24-dehydrocholesterol reductase
increases expression
ISO
Benzalkonium Compounds results in increased expression of DHCR24 mRNA
CTD
PMID:31199489
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dhcr7
7-dehydrocholesterol reductase
decreases activity increases expression
ISO
Benzalkonium Compounds results in decreased activity of DHCR7 protein Benzalkonium Compounds results in increased expression of DHCR7 mRNA
CTD
PMID:26919959
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dio1
iodothyronine deiodinase 1
decreases activity
ISO
Benzalkonium Compounds results in decreased activity of DIO1 protein
CTD
PMID:30561685
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dio2
iodothyronine deiodinase 2
decreases activity
ISO
Benzalkonium Compounds results in decreased activity of DIO2 protein
CTD
PMID:30561685
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Dio3
iodothyronine deiodinase 3
decreases activity
ISO
Benzalkonium Compounds results in decreased activity of DIO3 protein
CTD
PMID:30561685
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
G
Dlk1
delta like non-canonical Notch ligand 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of DLK1 mRNA
CTD
PMID:31199489
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of DUSP1 mRNA
CTD
PMID:30806763
NCBI chr10:16,680,478...16,683,275
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
Benzalkonium Compounds results in increased expression of DUSP10 mRNA
CTD
PMID:37149095
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Ebp
EBP, cholestenol delta-isomerase
increases expression
ISO
Benzalkonium Compounds results in increased expression of EBP mRNA
CTD
PMID:26919959
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
G
Egf
epidermal growth factor
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of EGF mRNA
CTD
PMID:30171875
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egr1
early growth response 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of EGR1 mRNA
CTD
PMID:25377654
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Elf3
E74 like ETS transcription factor 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of ELF3 mRNA
CTD
PMID:30171875
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Elovl1
ELOVL fatty acid elongase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ELOVL1 mRNA
CTD
PMID:29155129
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
G
Elovl6
ELOVL fatty acid elongase 6
increases expression
ISO
Benzalkonium Compounds results in increased expression of ELOVL6 mRNA
CTD
PMID:31199489
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Endou
endonuclease, poly(U)-specific
increases expression
ISO
Benzalkonium Compounds results in increased expression of ENDOU mRNA
CTD
PMID:30171875
NCBI chr 7:128,844,872...128,866,572
Ensembl chr 7:128,844,862...128,866,596
G
Eno1
enolase 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ENO1 mRNA
CTD
PMID:31199489
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
G
Etnk1
ethanolamine kinase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ETNK1 mRNA
CTD
PMID:31199489
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
G
Exo1
exonuclease 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of EXO1 mRNA
CTD
PMID:30171875
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
Ezr
ezrin
increases expression
ISO
Benzalkonium Compounds results in increased expression of EZR mRNA; Benzalkonium Compounds results in increased expression of EZR protein
CTD
PMID:29893927
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
Fam83a
family with sequence similarity 83, member A
increases expression
ISO
Benzalkonium Compounds results in increased expression of FAM83A mRNA
CTD
PMID:30171875
NCBI chr 7:89,522,826...89,547,284
Ensembl chr 7:89,522,826...89,547,388
G
Fgf2
fibroblast growth factor 2
affects response to substance
ISO
FGF2 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27206134
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
increases expression
ISO
Benzalkonium Compounds results in increased expression of FGR mRNA
CTD
PMID:30171875
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
G
Flg
filaggrin
increases expression
ISO
Benzalkonium Compounds results in increased expression of FLG mRNA
CTD
PMID:30171875
NCBI chr 2:178,884,793...178,912,986
G
Foxc1
forkhead box C1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXC1 mRNA
CTD
PMID:30171875
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
G
Foxn1
forkhead box N1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXN1 mRNA
CTD
PMID:30171875
NCBI chr10:63,251,400...63,273,710
Ensembl chr10:63,251,400...63,273,710
G
Foxp3
forkhead box P3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXP3 mRNA
CTD
PMID:30171875
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gata3
GATA binding protein 3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of GATA3 mRNA
CTD
PMID:30171875
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Benzalkonium Compounds results in increased expression of GCLC mRNA
CTD
PMID:30806763
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Benzalkonium Compounds results in increased expression of GCLM mRNA
CTD
PMID:30806763
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gpx2
glutathione peroxidase 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of GPX2 mRNA
CTD
PMID:30171875
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
Benzalkonium Compounds results in increased expression of HBEGF mRNA
CTD
PMID:30171875
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HCK mRNA
CTD
PMID:30171875
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of HERPUD1 mRNA
CTD
PMID:37149095
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hgf
hepatocyte growth factor
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HGF mRNA
CTD
PMID:30171875
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
Benzalkonium Compounds results in increased expression of HIF1A mRNA
CTD
PMID:30171875
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
Benzalkonium Compounds results in increased expression of HMGCR mRNA
CTD
PMID:26919959 PMID:31199489
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of HMGCS2 mRNA
CTD
PMID:31199489
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of HMOX1 mRNA
CTD
PMID:37149095
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hoxa7
homeobox A7
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of HOXA7 mRNA
CTD
PMID:30171875
NCBI chr 4:81,315,730...81,317,629
Ensembl chr 4:81,314,625...81,317,659
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
increases expression
ISO
Benzalkonium Compounds results in increased expression of HSD17B7 mRNA
CTD
PMID:31199489
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
G
Hspa5
heat shock protein family A (Hsp70) member 5
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of HSPA5 mRNA
CTD
PMID:28236482
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ICAM1 mRNA; Benzalkonium Compounds results in increased expression of ICAM1 protein
CTD
PMID:21742781 PMID:30806763
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id1
inhibitor of DNA binding 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ID1 mRNA
CTD
PMID:37149095
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of IDI1 mRNA
CTD
PMID:31199489
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ifng
interferon gamma
increases expression
ISO
Benzalkonium Compounds results in increased expression of IFNG protein
CTD
PMID:30517752
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
multiple interactions increases expression
ISO
Benzalkonium Compounds results in increased expression of and results in decreased secretion of IL10 protein Benzalkonium Compounds results in increased expression of IL10 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in decreased expression of IL10 protein
CTD
PMID:29953848 PMID:30517752 PMID:31158415
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13ra2
interleukin 13 receptor subunit alpha 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL13RA2 mRNA
CTD
PMID:30171875
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il15
interleukin 15
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL15 protein
CTD
PMID:30517752
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17f
interleukin 17F
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL17F mRNA
CTD
PMID:23445166
NCBI chr 9:23,190,094...23,201,482
Ensembl chr 9:23,190,100...23,201,482
G
Il18
interleukin 18
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL18 protein Benzalkonium Compounds results in increased expression of IL18 mRNA
CTD
PMID:30517752 PMID:30806763
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
increases secretion increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased secretion of IL1A protein Benzalkonium Compounds results in increased expression of IL1A mRNA; Benzalkonium Compounds results in increased expression of IL1A protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL1A protein
CTD
PMID:8006454 PMID:12781210 PMID:25290854 PMID:30240708 PMID:30517752 PMID:31158415 More...
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of IL1B protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL1B protein
CTD
PMID:29953848 PMID:30517752 PMID:31158415
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1f10
interleukin 1 family member 10
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of IL1F10 mRNA
CTD
PMID:30171875
NCBI chr 3:7,072,511...7,075,439
Ensembl chr 3:7,072,511...7,075,439
G
Il23a
interleukin 23 subunit alpha
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL23A mRNA
CTD
PMID:30171875
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il24
interleukin 24
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL24 mRNA
CTD
PMID:37149095
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Il27
interleukin 27
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL27 protein
CTD
PMID:30517752
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Il3
interleukin 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL3 protein
CTD
PMID:30517752
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il31
interleukin 31
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL31 protein
CTD
PMID:30517752
NCBI chr12:33,095,108...33,105,026
Ensembl chr12:33,092,097...33,105,037
G
Il31ra
interleukin 31 receptor A
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of IL31RA mRNA
CTD
PMID:30171875
NCBI chr 2:44,118,748...44,189,943
Ensembl chr 2:44,122,624...44,183,767
G
Il34
interleukin 34
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of IL34 mRNA
CTD
PMID:30171875
NCBI chr19:38,714,990...38,782,749
Ensembl chr19:38,714,991...38,764,000
G
Il36a
interleukin 36, alpha
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL36A mRNA
CTD
PMID:30171875
NCBI chr 3:6,996,851...7,001,400
Ensembl chr 3:6,996,851...7,001,400
G
Il36b
interleukin 36, beta
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL36B mRNA
CTD
PMID:30171875
NCBI chr 3:7,024,881...7,030,388
Ensembl chr 3:7,021,973...7,031,619
G
Il36g
interleukin 36, gamma
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL36G mRNA
CTD
PMID:30171875
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
G
Il4
interleukin 4
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of IL4 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in decreased expression of IL4 protein
CTD
PMID:30517752 PMID:31158415
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL5 protein
CTD
PMID:30517752
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
increases secretion increases expression multiple interactions affects response to substance
ISO
Benzalkonium Compounds results in increased secretion of IL6 protein Benzalkonium Compounds results in increased expression of IL6 mRNA Benzalkonium Compounds results in increased expression of and results in increased secretion of IL6 protein Benzalkonium Compounds results in increased expression of IL6 mRNA; Benzalkonium Compounds results in increased expression of IL6 protein IL6 protein affects the susceptibility to Benzalkonium Compounds [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ADRA2A mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of AGTR2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of C1S2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of C3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CD177 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CD274 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CTPS1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CXCL3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CXCL5 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXC1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXN1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXP3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of GATA3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of GSDMA3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HCK mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HGF mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of IGHA mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of IL1F10 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRT2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP14 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP16-3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP19-2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP19-5 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP19-9B mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP6-1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP6-2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of LTB mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP25 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP9 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MRGPRA2B mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MSX2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MYLK3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of NRG2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PDCD1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PROKR2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PTX3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of REG1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of REG3G mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of RYR1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SAA3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SERPINB13 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SIGLECE mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SOX21 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SRMS mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ST14 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TFAP2B mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFRSF13C mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFRSF26 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFSF8 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TSLP mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of VTCN1 mRNA; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL6 protein
CTD
PMID:17763283 PMID:28214551 PMID:29953848 PMID:30171875 PMID:30517752 PMID:31158415 PMID:31707104 More...
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
multiple interactions increases response to substance
ISO
[IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in decreased expression of IL10 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in decreased expression of IL4 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CCL3 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CCL4 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL10 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL2 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL1A protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL1B protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL22 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL6 protein
CTD
PMID:31158415
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Il7r
interleukin 7 receptor
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL7R mRNA
CTD
PMID:20713136
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Inhba
inhibin subunit beta A
increases expression
ISO
Benzalkonium Compounds results in increased expression of INHBA mRNA
CTD
PMID:30171875
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Insig1
insulin induced gene 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of INSIG1 mRNA
CTD
PMID:31199489
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Isl1
ISL LIM homeobox 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ISL1 mRNA
CTD
PMID:30171875
NCBI chr 2:48,079,412...48,090,704
Ensembl chr 2:48,080,522...48,095,584
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Benzalkonium Compounds inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Benzalkonium Compounds results in decreased activity of KCNH2 protein
CTD
PMID:24052561
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kdm7a
lysine demethylase 7A
increases expression
ISO
Benzalkonium Compounds results in increased expression of KDM7A mRNA
CTD
PMID:37149095
NCBI chr 4:67,899,407...67,974,264
Ensembl chr 4:67,904,307...67,966,998
G
Kdm8
lysine demethylase 8
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of KDM8 mRNA
CTD
PMID:31199489
NCBI chr 1:180,013,969...180,028,829
Ensembl chr 1:180,020,656...180,028,841
G
Klf2
KLF transcription factor 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of KLF2 mRNA
CTD
PMID:37149095
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
G
Klk8
kallikrein related-peptidase 8
increases expression
ISO
Benzalkonium Compounds results in increased expression of KLK8 mRNA
CTD
PMID:30171875
NCBI chr 1:94,251,803...94,258,646
Ensembl chr 1:94,251,803...94,258,646
G
Krt2
keratin 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRT2 mRNA
CTD
PMID:30171875
NCBI chr 7:132,940,879...132,948,031
Ensembl chr 7:132,940,862...132,947,963
G
Krtap14
keratin associated protein 14
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP14 mRNA
CTD
PMID:30171875
NCBI chr11:28,126,660...28,127,502
Ensembl chr11:28,126,660...28,127,502
G
Lce1m
late cornified envelope 1M
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of LCE1M mRNA
CTD
PMID:30171875
NCBI chr 2:178,637,495...178,638,697
Ensembl chr 2:178,637,495...178,638,697
G
Ldha
lactate dehydrogenase A
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of LDHA mRNA
CTD
PMID:31199489
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
Benzalkonium Compounds results in increased expression of LDLR mRNA
CTD
PMID:31199489
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
Benzalkonium Compounds results in increased expression of LIF protein
CTD
PMID:30517752
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
LOC120097198
U6 spliceosomal RNA
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of RNU6-643P
CTD
PMID:37149095
NCBI chr15:99,491,045...99,491,148
Ensembl chr15:99,491,045...99,491,148
G
LOC120100208
small nucleolar RNA SNORA71
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of SNORA71D mRNA
CTD
PMID:25377654
NCBI chr 1:232,131,169...232,131,300
Ensembl chr 1:232,131,169...232,131,300
G
Loxl1
lysyl oxidase-like 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of LOXL1 mRNA
CTD
PMID:31199489
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lst1
leukocyte specific transcript 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of LST1 mRNA
CTD
PMID:30171875
NCBI chr20:3,634,680...3,639,731
Ensembl chr20:3,634,749...3,637,997
G
Ltb
lymphotoxin beta
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of LTB mRNA
CTD
PMID:30171875
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Mapk14
mitogen activated protein kinase 14
increases phosphorylation
ISO
Benzalkonium Compounds results in increased phosphorylation of MAPK14 protein
CTD
PMID:15737199
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mesp2
mesoderm posterior bHLH transcription factor 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of MESP2 mRNA
CTD
PMID:30171875
NCBI chr 1:133,756,601...133,759,207
Ensembl chr 1:133,756,601...133,759,198
G
Mif
macrophage migration inhibitory factor
increases secretion
ISO
Benzalkonium Compounds results in increased secretion of MIF protein
CTD
PMID:31707104
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mmp10
matrix metallopeptidase 10
increases expression
ISO
Benzalkonium Compounds results in increased expression of MMP10 mRNA
CTD
PMID:30806763
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp12
matrix metallopeptidase 12
increases expression
ISO
Benzalkonium Compounds results in increased expression of MMP12 mRNA
CTD
PMID:30171875
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp2
matrix metallopeptidase 2
increases activity
EXP
Benzalkonium Compounds results in increased activity of MMP2 protein
CTD
PMID:21058936
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp25
matrix metallopeptidase 25
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP25 mRNA
CTD
PMID:30171875
NCBI chr10:12,661,297...12,676,119
Ensembl chr10:12,661,208...12,675,871
G
Mmp9
matrix metallopeptidase 9
multiple interactions increases activity
ISO EXP
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP9 mRNA Benzalkonium Compounds results in increased activity of MMP9 protein
CTD
PMID:21058936 PMID:30171875
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Msmo1
methylsterol monooxygenase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of MSMO1 mRNA
CTD
PMID:31199489
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Msx2
msh homeobox 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MSX2 mRNA
CTD
PMID:30171875
NCBI chr17:11,097,214...11,102,879
Ensembl chr17:11,097,103...11,102,879
G
Mt2A
metallothionein 2A
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of MT2 mRNA
CTD
PMID:31199489
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of MTHFD2 mRNA
CTD
PMID:31199489
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mylk3
myosin light chain kinase 3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MYLK3 mRNA
CTD
PMID:30171875
NCBI chr19:21,685,085...21,743,587
Ensembl chr19:21,691,929...21,742,954
G
Ndufa4
Ndufa4, mitochondrial complex associated
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of NDUFA4 mRNA
CTD
PMID:31199489
NCBI chr 4:40,002,216...40,009,384
Ensembl chr 4:40,002,216...40,023,920
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of NR4A2 mRNA
CTD
PMID:25377654
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nrg2
neuregulin 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of NRG2 mRNA
CTD
PMID:30171875
NCBI chr18:27,616,542...27,798,505
Ensembl chr18:27,619,661...27,798,505
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
affects response to substance
ISO
NTRK3 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27206134
NCBI chr 1:132,116,472...132,503,849
Ensembl chr 1:132,132,849...132,503,286
G
Ocln
occludin
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of OCLN protein
CTD
PMID:29514330
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Odc1
ornithine decarboxylase 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ODC1 mRNA
CTD
PMID:31199489
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Olr1
oxidized low density lipoprotein receptor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of OLR1 mRNA
CTD
PMID:30171875
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
G
Orm1
orosomucoid 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ORM1 mRNA
CTD
PMID:30171875
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
Benzalkonium Compounds analog results in increased cleavage of PARP1 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Benzalkonium Compounds analog results in increased cleavage of PARP1 protein]
CTD
PMID:31982400
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pbk
PDZ binding kinase
increases expression
ISO
Benzalkonium Compounds results in increased expression of PBK mRNA
CTD
PMID:30171875
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PCSK9 mRNA
CTD
PMID:31199489
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
G
Pdcd1
programmed cell death 1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PDCD1 mRNA
CTD
PMID:30171875
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pfdn6
prefoldin subunit 6
affects response to substance
ISO
PFDN6 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,945,959...4,947,433
Ensembl chr20:4,945,959...4,947,433
G
Pglyrp3
peptidoglycan recognition protein 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of PGLYRP3 mRNA
CTD
PMID:30171875
NCBI chr 2:177,479,693...177,490,769
Ensembl chr 2:177,477,407...177,490,736 Ensembl chr 2:177,477,407...177,490,736
G
Pgp
phosphoglycolate phosphatase
increases expression
ISO
Benzalkonium Compounds results in increased expression of PGP mRNA
CTD
PMID:31199489
NCBI chr10:13,495,232...13,497,858
Ensembl chr10:13,494,291...13,497,858
G
Pla2g5
phospholipase A2, group V
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PLA2G5 mRNA
CTD
PMID:30171875
NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
G
Plcxd3
phosphatidylinositol-specific phospholipase C, X domain containing 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of PLCXD3 mRNA
CTD
PMID:31199489
NCBI chr 2:53,567,022...53,746,384
Ensembl chr 2:53,567,022...53,746,384
G
Plk2
polo-like kinase 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PLK2 mRNA
CTD
PMID:37149095
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Pnpla2
patatin-like phospholipase domain containing 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PNPLA2 mRNA
CTD
PMID:31199489
NCBI chr 1:196,552,723...196,557,805
Ensembl chr 1:196,552,723...196,557,805
G
Polr1d
RNA polymerase I and III subunit D
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of POLR1D mRNA
CTD
PMID:31199489
NCBI chr12:7,970,592...8,004,157
Ensembl chr12:7,970,595...8,005,624
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PPARA mRNA
CTD
PMID:31199489
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of PRKAA2 mRNA
CTD
PMID:31199489
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prkag2
protein kinase AMP-activated non-catalytic subunit gamma 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of PRKAG2 mRNA
CTD
PMID:31199489
NCBI chr 4:10,010,890...10,252,155
Ensembl chr 4:10,010,890...10,252,142
G
Prokr2
prokineticin receptor 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PROKR2 mRNA
CTD
PMID:30171875
NCBI chr 3:119,624,738...119,639,442
Ensembl chr 3:119,627,601...119,635,718
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of PTGS2 mRNA
CTD
PMID:30806763
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptx3
pentraxin 3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PTX3 mRNA
CTD
PMID:30171875
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
Ralgdsl2
ral guanine nucleotide dissociation stimulator like 2
affects response to substance
ISO
RGL2 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,948,495...4,956,774
Ensembl chr20:4,948,497...4,969,911
G
Reg1a
regenerating family member 1 alpha
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of REG1 mRNA
CTD
PMID:30171875
NCBI chr 4:110,892,451...110,895,115
Ensembl chr 4:110,892,453...110,895,570
G
Reg3g
regenerating family member 3 gamma
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of REG3G mRNA
CTD
PMID:30171875
NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:110,924,168...110,926,723
G
Rps18
ribosomal protein S18
affects response to substance
ISO
RPS18 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,931,427...4,935,538
Ensembl chr20:4,931,768...4,938,315
G
RT1-DOa
RT1 class II, locus DOa
affects response to substance
ISO
HLA-DOA SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,753,598...4,756,577
G
RT1-DOb
RT1 class II, locus DOb
affects response to substance
ISO
HLA-DOB SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,619,418...4,625,627
Ensembl chr20:4,619,816...4,625,667
G
RT1-Ha
RT1 class II, locus Ha
affects response to substance
ISO
HLA-DPA1 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
affects response to substance
ISO
HLA-DPB1 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Ryr1
ryanodine receptor 1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of RYR1 mRNA
CTD
PMID:30171875
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
G
Scd
stearoyl-CoA desaturase
increases expression decreases expression
ISO
Benzalkonium Compounds results in increased expression of SCD mRNA Benzalkonium Compounds results in decreased expression of SCD1 mRNA
CTD
PMID:29155129 PMID:31199489
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Serpinb13
serpin family B member 13
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SERPINB13 mRNA
CTD
PMID:30171875
NCBI chr13:23,118,582...23,150,352
Ensembl chr13:23,118,584...23,150,760
G
Serpine1
serpin family E member 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of SERPINE1 mRNA
CTD
PMID:30171875
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sesn2
sestrin 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of SESN2 mRNA
CTD
PMID:31199489
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sfn
stratifin
increases expression
ISO
Benzalkonium Compounds results in increased expression of SFN mRNA
CTD
PMID:30171875
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
G
Sfrp4
secreted frizzled-related protein 4
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of SFRP4 mRNA
CTD
PMID:30171875
NCBI chr17:45,278,867...45,330,806
Ensembl chr17:45,234,097...45,330,736
G
Slc16a1
solute carrier family 16 member 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of SLC16A1 mRNA
CTD
PMID:31199489
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Benzalkonium Compounds results in increased expression of SLC7A11 mRNA
CTD
PMID:30806763 PMID:37149095
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Snora38
small nucleolar RNA, H/ACA box 38
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of SNORA38
CTD
PMID:37149095
NCBI chr20:3,660,900...3,661,033
Ensembl chr20:3,660,900...3,661,033 Ensembl chr 9:3,660,900...3,661,033
G
Sox21
SRY-box transcription factor 21
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SOX21 mRNA
CTD
PMID:30171875
NCBI chr15:95,292,429...95,296,024
Ensembl chr15:95,292,265...95,296,091
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR1A mRNA
CTD
PMID:30171875
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Sprr1b
small proline-rich protein 1B
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR1B mRNA
CTD
PMID:30171875
NCBI chr 2:178,008,844...178,010,742
Ensembl chr 2:178,009,130...178,009,567
G
Sprr2a
small proline rich protein 2A
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR2H mRNA
CTD
PMID:30171875
NCBI chr 2:177,815,964...177,816,236
Ensembl chr 2:177,815,964...177,816,236
G
Sprr2b
small proline rich protein 2B
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR2B mRNA
CTD
PMID:30171875
NCBI chr 2:177,852,824...177,853,096
Ensembl chr 2:177,852,824...177,853,096
G
Sprr2f
small proline rich protein 2F
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR2F mRNA
CTD
PMID:30171875
NCBI chr 2:177,989,974...177,990,204
Ensembl chr 2:177,989,974...177,990,204
G
Sqle
squalene epoxidase
increases expression
ISO
Benzalkonium Compounds results in increased expression of SQLE mRNA
CTD
PMID:31199489
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srebf2
sterol regulatory element binding transcription factor 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of SREBF2 mRNA
CTD
PMID:26919959
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Srms
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SRMS mRNA
CTD
PMID:30171875
NCBI chr 3:168,318,511...168,324,915
Ensembl chr 3:168,318,512...168,324,915
G
St14
ST14 transmembrane serine protease matriptase
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ST14 mRNA
CTD
PMID:30171875
NCBI chr 8:29,540,805...29,581,704
Ensembl chr 8:29,540,811...29,581,517
G
Tapbp
TAP binding protein
affects response to substance
ISO
TAPBP SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,956,937...4,966,191
Ensembl chr20:4,956,937...4,966,181
G
Tfap2b
transcription factor AP-2 beta
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TFAP2B mRNA
CTD
PMID:30171875
NCBI chr 9:21,786,251...21,816,054
Ensembl chr 9:21,786,258...21,814,520
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of TGFB1 protein
CTD
PMID:30517752
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgm3
transglutaminase 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of TGM3 mRNA
CTD
PMID:30171875
NCBI chr 3:117,228,661...117,264,078
Ensembl chr 3:117,228,661...117,264,075
G
Tgm7
transglutaminase 7
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of TGM7 mRNA
CTD
PMID:30171875
NCBI chr 3:108,051,890...108,068,116
Ensembl chr 3:108,051,890...108,076,239
G
Thbs1
thrombospondin 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of THBS1 mRNA
CTD
PMID:30171875
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Tlr1
toll-like receptor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of TLR1 mRNA
CTD
PMID:30171875
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr4
toll-like receptor 4
increases activity
ISO
Benzalkonium Compounds results in increased activity of TLR4 protein
CTD
PMID:29514330
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tmprss11b
transmembrane serine protease 11B
increases expression
ISO
Benzalkonium Compounds results in increased expression of TMPRSS11B mRNA
CTD
PMID:30171875
NCBI chr14:21,383,936...21,407,283
Ensembl chr14:21,383,862...21,408,817
G
Tnf
tumor necrosis factor
decreases secretion increases expression
ISO
Benzalkonium Compounds results in decreased secretion of TNF protein Benzalkonium Compounds results in increased expression of TNF mRNA; Benzalkonium Compounds results in increased expression of TNF protein
CTD
PMID:29953848 PMID:30171875 PMID:30517752
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Benzalkonium Compounds results in increased expression of TNFAIP6 mRNA
CTD
PMID:30171875
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfrsf13c
TNF receptor superfamily member 13C
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFRSF13C mRNA
CTD
PMID:30171875
NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:113,736,055...113,738,517
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
Benzalkonium Compounds results in increased expression of TNFRSF9 mRNA
CTD
PMID:30171875
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf8
TNF superfamily member 8
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFSF8 mRNA
CTD
PMID:30171875
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
G
Tp53
tumor protein p53
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of TP53 mRNA
CTD
PMID:28236482
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpi1
triosephosphate isomerase 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of TPI1 mRNA
CTD
PMID:31199489
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Trem2
triggering receptor expressed on myeloid cells 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of TREM2 mRNA
CTD
PMID:30171875
NCBI chr 9:12,647,605...12,654,190
Ensembl chr 9:12,647,259...12,654,170
G
Trib3
tribbles pseudokinase 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of TRIB3 mRNA
CTD
PMID:37149095
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Tslp
thymic stromal lymphopoietin
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TSLP mRNA
CTD
PMID:30171875
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Ulbp1
UL16 binding protein 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ULBP1 mRNA
CTD
PMID:37149095
NCBI chr 1:1,694,255...1,716,160
G
Upk3b
uroplakin 3B
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of UPK3B mRNA
CTD
PMID:30171875
NCBI chr12:20,630,231...20,637,634
Ensembl chr12:20,631,525...20,637,724
G
Uqcrq
ubiquinol-cytochrome c reductase, complex III subunit VII
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of UQCRQ mRNA
CTD
PMID:31199489
NCBI chr10:37,585,864...37,589,328
Ensembl chr10:37,586,888...37,589,169
G
Vegfd
vascular endothelial growth factor D
increases expression
ISO
Benzalkonium Compounds results in increased expression of VEGFD mRNA
CTD
PMID:20146380
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of VTCN1 mRNA
CTD
PMID:30171875
NCBI chr 2:188,253,594...188,321,658
Ensembl chr 2:188,253,594...188,321,658
G
Wdr46
WD repeat domain 46
affects response to substance
ISO
WDR46 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,937,845...4,945,796
Ensembl chr20:4,937,847...4,946,535
G
Xbp1
X-box binding protein 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of XBP1 mRNA alternative form
CTD
PMID:28236482
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xcl1
X-C motif chemokine ligand 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of XCL1 mRNA
CTD
PMID:30171875
NCBI chr13:77,248,687...77,252,343
Ensembl chr13:77,248,717...77,252,329
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all